Table 2.
Summary of samples used to identify and validate target indices
| Characteristic | Discovery cohorts | Validation cohorts | |||||
|---|---|---|---|---|---|---|---|
| |
GSE2034 |
GSE7390 |
GSE6532 |
GSE21094 |
GSE25055 |
GSE25065 |
GSE22513 |
| Samples |
286 |
198 |
327 |
278 |
310 |
198 |
14 |
| Regimen |
N/A |
N/A |
N/A |
TFAC |
AT |
AT |
T |
| |
|
|
|
|
|
|
U133 Plus |
| Array type |
U133A |
U133A |
U133A |
U133A |
U133A |
U133A |
2.0 |
| Total arrays: 811 | Total arrays: 800 | ||||||
Abbreviations: TFAC: paclitaxel/docetaxel, 5-fluorouracil, doxorubicin, cyclophosphamide; AT: doxorubicin, paclitaxel/docetaxel; T: docetaxel.